Previous 10 | Next 10 |
2024-02-25 18:50:34 ET More on Enovis Corporation, Paragon 28, etc. Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript Enovis Corporation Non-GAAP EPS of $0.79 beats by $0.05, revenue of $455.02M beats by $9.63M Enovis Corporation Q4 2023 Earnings Preview ...
2024-02-20 09:00:00 ET Summary Passive investing is causing a disconnect between fundamental analysis and market pricing, but see our Model Portfolio picks below. Market corrections happen to bring the market back to fair value. Daily Index Beaters uses a combination of fundam...
2024-02-18 12:00:00 ET More on Medtronic Medtronic Is A Healthy Portfolio Boost Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative Anti-obesity meds can expand the market ...
Shares of Stryker Corporation (NYSE: SYK) traded at a new 52-week high today and are currently trading at $350.56. So far today, approximately 53,279 shares have been exchanged, as compared to an average 30-day volume of 1.35M shares. Stryker Corporation operates as a medical technology compa...
2024-02-14 10:04:11 ET Stryker Corporation has experienced positive revenue growth over the past three years, with a reported net sales growth of 11.1% in 2023. The drivers behind this growth were higher unit volumes, higher prices, and lower costs. SYK has focused on limiting healthcare ...
2024-02-14 08:15:00 ET Summary Markets continued to go higher in early 2024 with the Dow adding 0.4% and the S&P remaining flat in January. Interest rates were kept steady again in a range of 5.25% to 5.5% with the market now projecting fewer hikes this year as the economy rem...
Stryker showcases commitment to innovation at AAOS 2024 Annual Meeting PR Newswire MAHWAH, N.J. , Feb. 13, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technology, showcases its commitment to innovation and technological advancement i...
(NewsDirect) Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solution...
2024-02-07 08:19:04 ET Summary Stryker is a leading medical technology company with a diversified product portfolio that targets orthopedic surgery amongst other end markets. Stryker is currently reaping the rewards of a decade of heavy investment (R&D and M&A), with growt...
2024-02-07 08:16:34 ET More on Stryker Stryker: A Dividend Growth Powerhouse I'd Like To Own Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript Stryker: Mako Shoulder And Spine Launches Are On The Way Canaccord upgrades Stryker to buy, cites growth po...
News, Short Squeeze, Breakout and More Instantly...
Stryker (NYSE: SYK), a global leader in medical technologies, has completed the previously announced acquisition of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures. “Integrating Artelon’...
Portage, Michigan, July 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, July 30, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases ...
Stryker joins Atrium Health affiliate IRCAD North America to advance surgical training and education PR Newswire PORTAGE, Michigan and CHARLOTTE, North Carolina , USA , June 18, 2024 /PRNewswire/ -- Stryker is bringing its innovative products, platforms and r...